Literature DB >> 11849316

Murine graft-versus-host disease induced using interferon-gamma-deficient grafts features antibodies to double-stranded DNA, T helper 2-type cytokines and hypereosinophilia.

Cynthia A Ellison1, David S Bradley, Jacqie M M Fischer, Kent T Hayglass, John G Gartner.   

Abstract

Acute, lethal graft-versus-host disease (GvHD) develops in B6D2F1 hybrid recipients of wild-type, C57BL/6, parental strain grafts; however, when interferon-gamma (IFN-gamma) gene knockout (gko) donors are used, the disease is prolonged and associated with a higher level of engraftment, particularly of T cells. Lesions containing large, mixed cellular infiltrates develop in the skin, liver, pancreas, salivary gland, lung and kidney. In our current study, we wished to determine whether GvHD features a preponderance of T helper 2 (Th2) cytokines in the absence of donor-derived IFN-gamma, and whether autoantibody production, commonly associated with chronic GvHD, also occurs. Because mitogen responsiveness is consistently suppressed in mice with acute GvHD, we wished to measure this response in recipients of IFN-gamma gko grafts. Our findings indicate that spleen cells from the latter produce interleukin (IL)-4, IL-5 and IL-13 in culture, but respond poorly to concanavalin A (Con A) and lipopolysaccharide (LPS). Their sera contain anti-nuclear antibodies (ANA), some of which are specific for double-stranded (ds)DNA and are predominantly immunoglobulin (Ig)M and IgG1. We also noted the presence of numerous eosinophils in the infiltrates developing within the target organs. In some respects, this syndrome bears resemblance to both systemic lupus erythematosus (SLE) and chronic GvHD. However, histological evidence of glomerulonephritis is lacking and proteinuria fails to develop in recipients of IFN-gamma gko grafts, suggesting that IFN-gamma may be necessary for the development of lupus nephritis. On a broader scope, our findings underscore the importance of IFN-gamma in the pathogenetic mechanism of GvHD, and demonstrate that the absence of this cytokine promotes the development of chronic GvHD and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849316      PMCID: PMC1782642          DOI: 10.1046/j.0019-2805.2001.01353.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.

Authors:  C Haas; B Ryffel; M Le Hir
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

2.  Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.

Authors:  E Williamson; P Garside; J A Bradley; I A More; A M Mowat
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

3.  Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases.

Authors:  E Gleichmann; S T Pals; A G Rolink; T Radaszkiewicz; H Gleichmann
Journal:  Immunol Today       Date:  1984-11

Review 4.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  IL-12 is a central mediator of acute graft-versus-host disease in mice.

Authors:  E Williamson; P Garside; J A Bradley; A M Mowat
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

Review 7.  The functional and histological basis for graft-versus-host-induced immunosuppression.

Authors:  W S Lapp; T Ghayur; M Mendes; M Seddik; T A Seemayer
Journal:  Immunol Rev       Date:  1985-12       Impact factor: 12.988

8.  IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS.

Authors:  R M BLAESE; C MARTINEZ; R A GOOD
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

Review 9.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.

Authors:  H Arase; N Arase; T Saito
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  4 in total

1.  Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.

Authors:  Jianyu Weng; Chang He; Peilong Lai; Chenwei Luo; Rong Guo; Suijing Wu; Suxia Geng; Andy Xiangpeng; Xialin Liu; Xin Du
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

2.  B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.

Authors:  Alfred Hj Kim; Jun-Jae Chung; Shreeram Akilesh; Ania Koziell; Sanjay Jain; Jeffrey B Hodgin; Mark J Miller; Thaddeus S Stappenbeck; Jeffrey H Miner; Andrey S Shaw
Journal:  JCI Insight       Date:  2017-11-02

3.  Effect of palifermin in a murine model of graft-versus-host disease (GVHD) associated with Th2 cytokine production, autoantibody production, and glomerulonephritis.

Authors:  Cynthia A Ellison; Ian W Gibson; Kent T Hayglass; John G Gartner
Journal:  J Clin Immunol       Date:  2006-09-02       Impact factor: 8.317

Review 4.  The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.